Related Experiment Video
Updated: Oct 25, 2025

14:14
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.0K
Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease
Josefine Waldthaler1, Miriam Bopp2, Nele Kühn3
1Department of Neurology, University of Marburg, Germany; CMBB - Center for Mind, Brain and Behavior, University of Marburg, Germany.
Brain Stimulation
|August 5, 2021
Summary
Imaging-guided Deep Brain Stimulation (DBS) programming using GUIDE XT™ software offers non-inferior motor symptom control for Parkinson's Disease (PD) patients compared to standard methods. This approach aids in optimizing complex DBS lead programming efficiently.
Area of Science:
- Neurology
- Neurosurgery
- Biomedical Engineering
Background:
- Deep Brain Stimulation (DBS) programming is becoming increasingly complex due to advanced lead designs requiring individualized optimization.
- Current programming methods can be time-consuming and require significant expertise.
Purpose of the Study:
- To compare the efficacy of imaging-guided DBS programming using GUIDE XT™ software against standard clinical programming for Parkinson's Disease (PD) motor symptoms.
- To evaluate the relationship between the volume of the electrostatic field (VEsF) and motor symptom improvement.
Main Methods:
- 29 PD patients with bilateral Subthalamic Nucleus (STN) directional DBS leads underwent clinical evaluation for optimal parameters.
- A second DBS program was generated using GUIDE XT™ software, visualizing leads within patient-specific MRI/CT anatomy.
- Motor symptom reduction (MDS-UPDRS) and VEsF overlap between the two programming methods were compared.
Main Results:
- Both clinical and imaging-guided programming significantly reduced motor symptoms (MDS-UPDRS) compared to the off-state.
- GUIDE XT™-derived DBS programming achieved non-inferior motor symptom control compared to standard clinical programming.
- The overlap of the VEsFs from both programming methods did not correlate with the observed differences in motor symptom reduction.
Conclusions:
- Imaging-guided programming of directional DBS leads with GUIDE XT™ is feasible without requiring a computational background.
- This method provides non-inferior motor symptom control for PD patients, serving as a potential starting point for clinical testing.
- Patient-specific imaging data can promote more efficient DBS programming.

